(Q47441762)

16 January 2018

title

Duration of hormone replacement therapy, breast tumour size and grade in a screening programme (English)

1 reference

16 January 2018

Hormone Replacement Therapy

main subject

1 reference

5

Anne M Kavanagh

1 reference

16 January 2018

Dorota M. Gertig

1

object named as

Dorota M Gertig

1 reference

16 January 2018

Bircan Erbas

2

object named as

Bircan Erbas

1 reference

16 January 2018

author name string

Ashley Fletcher

3

1 reference

16 January 2018

Alison Amos

4

1 reference

16 January 2018

language of work or name

English

0 references

publication date

1 August 2003

1 reference

16 January 2018

Breast Cancer Research and Treatment

published in

1 reference

16 January 2018

volume

80

1 reference

16 January 2018

issue

3

1 reference

16 January 2018

page(s)

267-273

1 reference

16 January 2018

Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

Monitoring interval cancers in an Australian mammographic screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Hormone replacement therapy and accuracy of mammographic screening

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Tumour development, histology and grade of breast cancers: Prognosis and progression

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Postmenopausal hormone therapy and mortality.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Hormone replacement therapy in relation to breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Low biologic aggressiveness in breast cancer in women using hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Prognostic characteristics in breast cancers after hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Estrogen replacement therapy and breast cancer: analysis of age of onset and tumor characteristics

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Use of hormone replacement therapy by Melbourne women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Case-control study of factors associated with failure to detect breast cancer by mammography

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Does a better grade of tumour occurring in women under hormone replacement therapy compensate for their lower probability of detection by screening mammography

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1024953926221

7 January 2021

Identifiers

DOI

10.1023/A:1024953926221

1 reference

16 January 2018

Dimensions Publication ID

1005559641

0 references

1 reference

16 January 2018